NetworkNewsBreaks – AzurRx BioPharma Inc. (NASDA
Post# of 66
(Total Views: 254)
Posted On: 02/16/2021 2:40:49 PM
NetworkNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Participation in Microcap Rodeo Winter Wonderland Conference
AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of nonsystemic, recombinant therapies for gastrointestinal diseases, has announced that it will present at the upcoming Microcap Rodeo Winter Wonderland Conference. The virtual conference is slated for Feb. 16–19, 2021. AzurRx CEO James Sapirstein is scheduled to make a live company presentation during the conference. The AzurRx presentation is scheduled for 4:30 p.m. ET on Feb. 17. During the presentation, Sapirstein will provide an overview of AzurRx’s business and clinical development programs; he will also talk about milestones anticipated throughout the coming year. Following the presentation, Sapirstein and other AzurRx executives will be available to meet one-on-one with registered investors.
To register for the event, visit https://nnw.fm/qgGRp
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of nonsystemic, recombinant therapies for gastrointestinal diseases, has announced that it will present at the upcoming Microcap Rodeo Winter Wonderland Conference. The virtual conference is slated for Feb. 16–19, 2021. AzurRx CEO James Sapirstein is scheduled to make a live company presentation during the conference. The AzurRx presentation is scheduled for 4:30 p.m. ET on Feb. 17. During the presentation, Sapirstein will provide an overview of AzurRx’s business and clinical development programs; he will also talk about milestones anticipated throughout the coming year. Following the presentation, Sapirstein and other AzurRx executives will be available to meet one-on-one with registered investors.
To register for the event, visit https://nnw.fm/qgGRp
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Entero Therapeutics Inc. (ENTO) Stock Research Links
Scroll down for more posts ▼